Clinical trial
Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
NCT03987152 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 18, 2017
- Completion date
- March 1, 2023
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.